Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2018-02-24 00:53 CET (UTC+1h)

GMP: EMA and FDA – mutual recognition of inspections [GxP / QC / QA]

posted by DavidManteigas - Portugal, 2017-11-14 15:47  - Posting: # 17980
Views: 565

Thumbs up for El Maestro post! :clap:

Although I may understand the cost issue, I can't understand why pharmaceutical companies that outsource most of their R&D and manufacturing activities don't think and behave as you've described. They should be as interested as the regulatory authorities in assuring that the highest standards are followed by their vendors. When something goes wrong, and as the "vigilance" decreases the probability of lack of compliance increases, it's their brands and products that feel the consequences, as well as the market as a whole. Unless they all believe that there isn't such thing as bad publicity.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,939 Posts in 3,821 Threads, 1,122 registered users;
23 users online (0 registered, 23 guests).

In general, scientific progress calls for no more
than the absorption and elaboration of new ideas –
and this is a call most scientists are happy to heed.    Werner Heisenberg

BEBAC Ing. Helmut Schütz